Goldman Sachs’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.7M | Buy |
|
|||||
|
2025
Q1 | $6.46M | Buy |
|
|||||
|
2024
Q4 | $4.18M | Sell |
|
|||||
|
2024
Q3 | $5.07M | Sell |
|
|||||
|
2024
Q2 | $6.29M | Buy |
|
|||||
|
2024
Q1 | $11M | Buy |
|
|||||
|
2023
Q4 | $6.6M | Buy |
|
|||||
|
2023
Q3 | $2.73M | Sell |
|
|||||
|
2023
Q2 | $5.01M | Buy |
|
|||||
|
2023
Q1 | $3.79M | Sell |
|
|||||
|
2022
Q4 | $7.63M | Buy |
|
|||||
|
2022
Q3 | $10.4M | Buy |
|
|||||
|
2022
Q2 | $1.14M | Sell |
|
|||||
|
2022
Q1 | $2.43M | Buy |
|
|||||
|
2021
Q4 | $1.93M | Buy |
|
|||||
|
2021
Q3 | $1.98M | Sell |
|
|||||
|
2021
Q2 | $7.14M | Buy |
|